Correction to "A Selective and Brain Penetrant p38αMAPK Inhibitor Candidate for Neurologic and Neuropsychiatric Disorders That Attenuates Neuroinflammation and Cognitive Dysfunction"
J Med Chem. 2020 Aug 13;63(15):8649.
doi: 10.1021/acs.jmedchem.0c01060.
Epub 2020 Jul 16.